Levesialle Continu

Ethinylestradiol, the active ingredient in Levesialle Continu, is a combined oral contraceptive presented as a tablet for oral use. It works together with levonorgestrel to prevent pregnancy in women of reproductive age and to regulate menstrual cycles when prescribed. The formulation includes lactose as an inactive filler.

GNH USA supplies Levesialle Continu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with consistent quality assurance and regulatory compliance across EU markets. The company ensures timely delivery and supports local regulatory submissions.

Levesialle Continu, a combined oral contraceptive, acts on the hypothalamic‑pituitary‑ovarian axis to prevent ovulation.

Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. Menstrual cycle regulation: provides more predictable periods and reduces menstrual flow when used continuously. Acne treatment: improves acne vulgaris in women by reducing androgenic activity.

Levesialle Continu may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Headache - Breast tenderness - Spotting between periods - Mild weight gain - Mood changes

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Stroke or transient ischemic attack - Myocardial infarction - Severe allergic reaction (anaphylaxis) - Liver tumor or cholestatic jaundice - Hyperglycaemia in diabetic patients

Before prescribing Levesialle Continu, clinicians should evaluate individual risk factors and counsel patients on safe use. - Assess cardiovascular risk: review history of thromboembolic disorders before initiating therapy. - Avoid smoking: patients over 35 who smoke should not use combined oral contraceptives. - Monitor blood pressure: check regularly during treatment. - Consider liver function: adjust or avoid use in significant hepatic impairment. - Review drug interactions: assess concomitant medications that may affect hormone levels. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Levesialle Continu can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may reduce contraceptive efficacy. - HIV protease inhibitors: decrease hormone levels, increasing risk of contraceptive failure. - Strong enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): increase hormone metabolism, reducing effectiveness.

Moderate Interactions (Monitor Closely): - Rifampin and other broad‑spectrum antibiotics: may lower hormone concentrations. - St. John’s wort: enzyme inducer that can reduce contraceptive efficacy. - Diuretics: may increase the risk of hypertension while on combined oral contraceptives.